Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Ellis, James K ^a   Athersuch, Toby J ^a,b   Thomas, Laura D K ^a,c   Teichert, Friederike ^d   Pérez Trujillo, Miriam ^f   Svendsen, Claus ^e   Spurgeon, David J ^e   Singh, Rajinder ^d   Järup, Lars ^a,b   Bundy, Jacob G ^a,b   Keun, Hector C ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cadmium; Environmental health; Exposome; Metabolomics; Metabonomics; Molecular epidemiology

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CADMIUM; CREATINE; CREATININE; DIMETHYLGLYCINE; TOXIC GAS; ZINC; 8 OXO 7 HYDRODEOXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; CITRIC ACID; DEOXYGUANOSINE; DRUG DERIVATIVE;

ADULT; ARTICLE; CARBON METABOLISM; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLISM; MITOCHONDRIAL RESPIRATION; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; POLLUTION; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; SMELTER; SPECTROSCOPY; UNIVARIATE ANALYSIS; URINE LEVEL; VOLUNTEER; GENOTYPE ENVIRONMENT INTERACTION; METABOLOMICS; MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; URINE;

BIOLOGICAL MARKERS; CADMIUM; CITRIC ACID; DEOXYGUANOSINE; ENVIRONMENTAL EXPOSURE; GENE-ENVIRONMENT INTERACTION; HUMANS; LIFE STYLE; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84862271814     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-61     Document Type: Article

References (55)

1. Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis 2009, 24:117-125. 2720689, 19033256.
2. Vineis P, Perera F. Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 2007, 16:1954-1965. 10.1158/1055-9965.EPI-07-0457, 17932342.
3. Chadeau-Hyam M, Athersuch TJ, Keun HC, De IM, Ebbels TM, Jenab M, Sacerdote C, Bruce SJ, Holmes E, Vineis P. Meeting-in-the-middle using metabolic profiling - a strategy for the identification of intermediate biomarkers in cohort studies. Biomarkers 2011, 16:83-88. 10.3109/1354750X.2010.533285, 21114379.
4. Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science 2010, 330:460-461. 10.1126/science.1192603, 20966241.
5. Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005, 14:1847-1850. 10.1158/1055-9965.EPI-05-0456, 16103423.
6. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189. 10.1080/004982599238047, 10598751.
7. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002, 1:153-161. 10.1038/nrd728, 12120097.
8. Keun HC. Metabonomic modeling of drug toxicity. Pharmacol Ther 2006, 109:92-106. 10.1016/j.pharmthera.2005.06.008, 16051371.
9. Coen M, Holmes E, Lindon JC, Nicholson JK. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008, 21:9-27. 10.1021/tx700335d, 18171018.
10. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De IM, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453:396-400. 10.1038/nature06882, 18425110.
11. Spurgeon DJ, Lawlor A, Hooper HL, Wadsworth R, Svendsen C, Thomas LD, Ellis JK, Bundy JG, Keun HC, Jarup L. Outdoor and indoor cadmium distributions near an abandoned smelting works and their relations to human exposure. Environ Pollut 2011, 159:3425-3432. 10.1016/j.envpol.2011.08.028, 21908085.
12. Nriagu JO, Pacyna JM. Quantitative assessment of worldwide contamination of air, water and soils by trace metals. Nature 1988, 333:134-139. 10.1038/333134a0, 3285219.
13. Nriagu JO. A silent epidemic of environmental metal poisoning?. Environ Pollut 1988, 50:139-161. 10.1016/0269-7491(88)90189-3, 15092656.
14. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand J Work Environ Health 1998, 24(Suppl 1):1-51.
15. Jarup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 2009, 238:201-208. 10.1016/j.taap.2009.04.020, 19409405.
16. Jarup L, Hellstrom L, Alfven T, Carlsson MD, Grubb A, Persson B, Pettersson C, Spang G, Schutz A, Elinder CG. Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 2000, 57:668-672. 10.1136/oem.57.10.668, 1739874, 10984338.
17. Akesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C, Samsioe G, Stromberg U, Skerfving S. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 2005, 113:1627-1631. 10.1289/ehp.8033, 1310929, 16263522.
18. Elinder CG, Edling C, Lindberg E, Kagedal B, Vesterberg O. Assessment of renal function in workers previously exposed to cadmium. Br J Ind Med 1985, 42:754-760. 1007572, 3904816.
19. Elinder CG, Edling C, Lindberg E, Kagedal B, Vesterberg O. beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses. Am J Ind Med 1985, 8:553-564. 10.1002/ajim.4700080607, 3907336.
20. Hellstrom L, Elinder CG, Dahlberg B, Lundberg M, Jarup L, Persson B, Axelson O. Cadmium exposure and end-stage renal disease. Am J Kidney Dis 2001, 38:1001-1008. 10.1053/ajkd.2001.28589, 11684553.
21. Waalkes MP, Rehm S, Cherian MG. Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. Toxicol Sci 2000, 54:110-120. 10.1093/toxsci/54.1.110, 10746938.
22. Huff J, Lunn RM, Waalkes MP, Tomatis L, Infante PF. Cadmium-induced cancers in animals and in humans. Int J Occup Environ Health 2007, 13:202-212.
23. International Agency for Research on Cancer (IARC) Monographs on the Evaluation of the Carcinogenic Risks to Humans. Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry. IARC Scientific Publications 1993, 119-238. International Agency for Research on Cancer (IARC).
24. U.S. Department of Health and Human Services National Toxiclogy Program. Tenth Report on Carcinogens 2000, Research Triangle Park, NC, U.S. Department of Health and Human Services.
25. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, Clarke R, Sholler PF, Lirio AA, Foss C, Reiter R, Trock B, Paik S, Martin MB. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 2003, 9:1081-1084. 10.1038/nm902, 12858169.
26. Liu Z, Yu X, Shaikh ZA. Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium. Toxicol Appl Pharmacol 2008, 228:286-294. 10.1016/j.taap.2007.12.017, 18275979.
27. Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 2000, 14:545-553. 10.1210/me.14.4.545, 10770491.
28. Jin YH, Clark AB, Slebos RJ, Al-Refai H, Taylor JA, Kunkel TA, Resnick MA, Gordenin DA. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat Genet 2003, 34:326-329. 10.1038/ng1172, 2662193, 12796780.
29. Jiang G, Xu L, Song S, Zhu C, Wu Q, Zhang L, Wu L. Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 2008, 244:49-55. 10.1016/j.tox.2007.10.028, 18077075.
30. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect 2007, 115:1454-1459. 2022656, 17938735.
31. Oh SH, Lim SC. A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation. Toxicol Appl Pharmacol 2006, 212:212-223. 10.1016/j.taap.2005.07.018, 16169029.
32. Godt J, Scheidig F, Grosse-Siestrup C, Esche V, Brandenburg P, Reich A, Groneberg DA. The toxicity of cadmium and resulting hazards for human health. J Occup Med Toxicol 2006, 1:22. 10.1186/1745-6673-1-22, 1578573, 16961932.
33. Griffin JL, Walker LA, Troke J, Osborn D, Shore RF, Nicholson JK. The initial pathogenesis of cadmium induced renal toxicity. FEBS Lett 2000, 478:147-150. 10.1016/S0014-5793(00)01843-3, 10922487.
34. Griffin JL, Walker LA, Shore RF, Nicholson JK. Metabolic profiling of chronic cadmium exposure in the rat. Chem Res Toxicol 2001, 14:1428-1434. 10.1021/tx015521u, 11599935.
35. Nicholson JK, Higham DP, Timbrell JA, Sadler PJ. Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Mol Pharmacol 1989, 36:398-404.
36. Nicholson JK, Kendall MD, Osborn D. Cadmium and mercury nephrotoxicity. Nature 1983, 304:633-635. 10.1038/304633a0, 6877384.
37. Thomas LD, Hodgson S, Nieuwenhuijsen M, Jarup L. Early kidney damage in a population exposed to cadmium and other heavy metals. Environ Health Perspect 2009, 117:181-184. 2649217, 19270785.
38. Hwang TL, Shaka AJ. Water suppression that works - excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J Magn Reson Series A 1995, 112:275-279.
39. Fan TWM. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog Nucl Magn Reson Spectrosc 1996, 28:161-219.
40. Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, Hudson J, Blancher C, Gauguier D, Lindon JC, Holmes E, Nicholson J. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal Chem 2005, 77:1282-1289. 10.1021/ac048630x, 15732908.
41. Appiah-Amponsah E, Shanaiah N, Nagana Gowda GA, Owusu-Sarfo K, Ye T, Raftery D. Identification of 4-deoxythreonic acid present in human urine using HPLC and NMR techniques. J Pharm Biomed Anal 2009, 50:878-885. 10.1016/j.jpba.2009.06.007, 2861046, 19615840.
42. Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem 2006, 78:4281-4290. 10.1021/ac051632c, 16808434.
43. Teichert F, Verschoyle RD, Greaves P, Thorpe JF, Mellon JK, Steward WP, Farmer PB, Gescher AJ, Singh R. Determination of 8-oxo-2'-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies. Rapid Commun Mass Spectrom 2009, 23:258-266. 10.1002/rcm.3873, 19072863.
44. Shih CM, Ko WC, Wu JS, Wei YH, Wang LF, Chang EE, Lo TY, Cheng HH, Chen CT. Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5 fibroblasts. J Cell Biochem 2004, 91:384-397. 10.1002/jcb.10761, 14743397.
45. Badisa VL, Latinwo LM, Odewumi CO, Ikediobi CO, Badisa RB, Ayuk-Takem LT, Nwoga J, West J. Mechanism of DNA damage by cadmium and interplay of antioxidant enzymes and agents. Environ Toxicol 2007, 22:144-151. 10.1002/tox.20248, 17366568.
46. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 2004, 567:1-61. 10.1016/j.mrrev.2003.11.001, 15341901.
47. Loft S, Hogh DP, Mikkelsen L, Risom L, Forchhammer L, Moller P. Biomarkers of oxidative damage to DNA and repair. Biochem Soc Trans 2008, 36:1071-1076. 10.1042/BST0361071, 18793191.
48. CSTEE Opinion on the Results of the Risk Assessment of: Cadmium Metal Human Health (CAS no.:7440-43-9, EINECS no.:231-152-8) Cadmium Oxide Human Health (CAS no.:1306-19-0, EINECS no.:215-146-2) 2004, CSTEE.
49. JECFA (FAO/WHO) Evaluation of certain food additives and contaminants WHO food additives series, No. 52 2004, JECFA (FAO/WHO).
50. Hamm LL. Renal handling of citrate. Kidney Int 1990, 38:728-735. 10.1038/ki.1990.265, 2232510.
51. Cardellach F, Alonso JR, Lopez S, Casademont J, Miro O. Effect of smoking cessation on mitochondrial respiratory chain function. J Toxicol Clin Toxicol 2003, 41:223-228. 10.1081/CLT-120021102, 12807302.
52. Miro O, Alonso JR, Jarreta D, Casademont J, Urbano-Marquez A, Cardellach F. Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 1999, 20:1331-1336. 10.1093/carcin/20.7.1331, 10383908.
53. Chalkley SR, Richmond J, Barltrop D. Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium. Occup Environ Med 1998, 55:446-452. 10.1136/oem.55.7.446, 1757616, 9816377.
54. Belyaeva EA, Dymkowska D, Wieckowski MR, Wojtczak L. Mitochondria as an important target in heavy metal toxicity in rat hepatoma AS-30D cells. Toxicol Appl Pharmacol 2008, 231:34-42. 10.1016/j.taap.2008.03.017, 18501399.
55. Ballevre O, Prugnaud J, Houlier ML, Arnal M. Assessment of threonine metabolism in vivo by gas chromatography/mass spectrometry and stable isotope infusion. Anal Biochem 1991, 193:212-219. 10.1016/0003-2697(91)90011-H, 1908193.